1
|
Spinelli L, Martini S, Solla SD, Vigna Taglianti R, Olivero F, Gianello L, Reali A, Merlotti AM, Franco P. Nodal Elective Volume Selection and Definition during Radiation Therapy for Early Stage (T1-T2 N0 M0) Perianal Squamous Cell Carcinoma: A Narrative Clinical Review and Critical Appraisal. Cancers (Basel) 2023; 15:5833. [PMID: 38136378 PMCID: PMC10741760 DOI: 10.3390/cancers15245833] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2023] [Revised: 12/08/2023] [Accepted: 12/12/2023] [Indexed: 12/24/2023] Open
Abstract
Distinction between anal canal and perianal squamous cell carcinomas (pSCCs) is essential, as these two subgroups have different anatomical, histological, and lymphatic drainage features. Early-stage true perianal tumors are very uncommon and have been rarely included in clinical trials. Perianal skin cancers and aCCs are included in the same tumor classification, even though they have different lymphatic drainage features. Furthermore, pSCCs are treated similarly to carcinomas originating from the anal canal. Radiation therapy (RT) is an essential treatment for anal canal tumors. Guidelines do not differentiate between treatment volumes for perianal tumors and anal cancers. So far, in pSCC, no study has considered modulating treatment volume selection according to the stage of the disease. We conducted a narrative literature review to describe the sites at higher risk for microscopic disease in patients with early-stage perianal cancers (T1-T2 N0 M0) to propose a well-thought selection of RT elective volumes.
Collapse
Affiliation(s)
- Lavinia Spinelli
- Radiation Oncology Department, Santa Croce and Carle Hospital, 12100 Cuneo, Italy; (L.S.); (S.M.); (S.D.S.); (R.V.T.); (F.O.); (L.G.); (A.M.M.)
| | - Stefania Martini
- Radiation Oncology Department, Santa Croce and Carle Hospital, 12100 Cuneo, Italy; (L.S.); (S.M.); (S.D.S.); (R.V.T.); (F.O.); (L.G.); (A.M.M.)
| | - Salvatore Dario Solla
- Radiation Oncology Department, Santa Croce and Carle Hospital, 12100 Cuneo, Italy; (L.S.); (S.M.); (S.D.S.); (R.V.T.); (F.O.); (L.G.); (A.M.M.)
| | - Riccardo Vigna Taglianti
- Radiation Oncology Department, Santa Croce and Carle Hospital, 12100 Cuneo, Italy; (L.S.); (S.M.); (S.D.S.); (R.V.T.); (F.O.); (L.G.); (A.M.M.)
| | - Francesco Olivero
- Radiation Oncology Department, Santa Croce and Carle Hospital, 12100 Cuneo, Italy; (L.S.); (S.M.); (S.D.S.); (R.V.T.); (F.O.); (L.G.); (A.M.M.)
| | - Luca Gianello
- Radiation Oncology Department, Santa Croce and Carle Hospital, 12100 Cuneo, Italy; (L.S.); (S.M.); (S.D.S.); (R.V.T.); (F.O.); (L.G.); (A.M.M.)
| | - Alessia Reali
- Radiation Oncology Department, Michele and Pietro Ferrero Hospital, 12060 Verduno, Italy;
| | - Anna Maria Merlotti
- Radiation Oncology Department, Santa Croce and Carle Hospital, 12100 Cuneo, Italy; (L.S.); (S.M.); (S.D.S.); (R.V.T.); (F.O.); (L.G.); (A.M.M.)
| | - Pierfrancesco Franco
- Department of Translational Medicine (DIMET), University of Eastern Piedmont, 28100 Novara, Italy
- Department of Radiation Oncology, ‘Maggiore della Carità’ University Hospital, 28100 Novara, Italy
| |
Collapse
|
2
|
Queirolo P, Cinquini M, Argenziano G, Bassetto F, Bossi P, Boutros A, Clemente C, de Giorgi V, Del Vecchio M, Patuzzo R, Peris K, Quaglino P, Reali A, Zalaudek I, Spagnolo F. Guidelines for the diagnosis and treatment of basal cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology. ESMO Open 2023; 8:102037. [PMID: 37879235 PMCID: PMC10598491 DOI: 10.1016/j.esmoop.2023.102037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2023] [Accepted: 09/20/2023] [Indexed: 10/27/2023] Open
Abstract
Basal cell carcinoma (BCC) is the most common form of cancer, with a high impact on the public health burden and social costs. Despite the overall prognosis for patients with BCC being excellent, if lesions are allowed to progress, or in a small subset of cases harboring an intrinsically aggressive biological behavior, it can result in local spread and significant morbidity, and conventional treatments (surgery and radiotherapy) may be challenging. When a BCC is not amenable to either surgery or radiotherapy with a reasonable curative intent, or when metastatic spread occurs, systemic treatments with Hedgehog inhibitors are available. These guidelines were developed, applying the GRADE approach, on behalf of the Italian Association of Medical Oncologists (AIOM) to assist clinicians in treating patients with BCC. They contain recommendations with regard to the diagnosis, treatment and follow-up, from primitive tumors to those locally advanced or metastatic, addressing the aspects of BCC management considered as priorities by a panel of experts selected by AIOM and other national scientific societies. The use of these guidelines in everyday clinical practice should improve patient care.
Collapse
Affiliation(s)
- P Queirolo
- Division of Melanoma, Sarcomas and Rare Tumors, European Institute of Oncology, Milan
| | - M Cinquini
- Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan
| | - G Argenziano
- Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, Naples
| | - F Bassetto
- Clinic of Plastic Surgery, Department of Neuroscience, Padua University Hospital, Padua
| | - P Bossi
- Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health University of Brescia, ASST-Spedali Civili, Brescia
| | - A Boutros
- Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genoa, Genoa
| | - C Clemente
- UO SMEL-2, Surgical Pathology, Department of Pathology and Laboratory Medicine, IRCCS-Policlinico San Donato, Milan
| | - V de Giorgi
- Dermatology Unit, Azienda USL Toscana Centro, Florence; Section of Dermatology, Department of Health Sciences, University of Florence, Florence
| | - M Del Vecchio
- Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
| | - R Patuzzo
- Fondazione IRCCS Istituto Nazionale Dei Tumori, Melanoma and Sarcoma Unit, Milan
| | - K Peris
- Dermatology, Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome; Dermatology, Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome
| | - P Quaglino
- Department of Medical Sciences, Clinic of Dermatology, University of Turin, Turin
| | - A Reali
- Radiation Oncology Department, Michele e Pietro Ferrero Hospital, Verduno
| | - I Zalaudek
- Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste
| | - F Spagnolo
- Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genoa; Department of Integrated Surgical and Diagnostic Sciences (DISC), University of Genoa, Genoa, Italy.
| |
Collapse
|
3
|
Di Muzio N, Lorenzo G, Deantoni C, Cozzarini C, Fodor A, Briganti A, Montorsi F, Perez-Garcia V, Gomez H, Reali A. PO-1423 PSA dynamics forecasts identify tumor recurrence after external radiotherapy for prostate cancer. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)03387-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
4
|
Vigna‐Taglianti R, Boriano A, Gianello L, Melano A, Bergesio F, Merlotti AM, Reali A, Petrucci R, Russi EG. Predictive value of Prostate Specific Antigen variations in the last week of salvage radiotherapy for biochemical recurrence of prostate cancer after surgery: A practical approach. Cancer Rep (Hoboken) 2020; 3:e1285. [PMID: 32881424 PMCID: PMC7941543 DOI: 10.1002/cnr2.1285] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2020] [Revised: 07/01/2020] [Accepted: 08/02/2020] [Indexed: 11/11/2022] Open
Abstract
BACKGROUND About a third of patients who underwent radical prostatectomy for prostate cancer (Pca) develop a biochemical failure (BF) within 10 years from surgery, and about a half of them receive salvage radiation therapy (SRT). Factors to predict risk to relapse after SRT are still lacking. Dynamic models, based on the assessment of changes in Prostate Specific Antigen (PSA) postsurgery seem to show good reliability. AIMS The goal of the study was to identify a simple analytical method for the postsalvage radiation therapy biochemical failure (post-SRTBF) prediction before the end of the SRT, regardless of the PSA value at the beginning of the treatment (PSA start), measuring the PSA values at the start and 1 week before the end of SRT. METHODS In a series of 83 patients treated with SRT for BF of Pca we measured PSA values at the first day and 1 week before the end of SRT. These values were used to define an analytical method for the post-SRTBF prediction. RESULTS PSA value in patients without post-SRTBF show a significant difference in term of difference during the SRT with respect to patients with post-SRTBF. Starting from this difference, we identified a simple and practical analytical method for the post-SRTBF prediction before the end of the SRT. The data corresponds with the model and the analytical method is highly predictive (Sensitivity = 81%, Specificity = 85%, Accuracy = 83%). CONCLUSION This study offers a new tool to early predict Pca relapse overtime and to select patients who can benefit from an early additional systemic treatment.
Collapse
Affiliation(s)
| | - Alberto Boriano
- Medical Physics DepartmentSanta Croce and Carle HospitalCuneoItaly
| | - Luca Gianello
- Radiation Oncology DepartmentSanta Croce and Carle HospitalCuneoItaly
| | - Antonella Melano
- Radiation Oncology DepartmentSanta Croce and Carle HospitalCuneoItaly
| | | | | | - Alessia Reali
- Radiation Oncology DepartmentSanta Croce and Carle HospitalCuneoItaly
| | - Rachele Petrucci
- Radiation Oncology DepartmentSanta Croce and Carle HospitalCuneoItaly
| | - Elvio G. Russi
- Radiation Oncology DepartmentSanta Croce and Carle HospitalCuneoItaly
| |
Collapse
|
5
|
Merlano M, Paccagnella M, Garrone O, Falletta A, Fea E, Abbona A, Lo Nigro C, Gammaitoni L, Vanella P, Monteverde M, Granetto C, Occelli M, Denaro N, Merlotti A, Reali A, Sangiolo D. 1950P TRANSLATE: Activation of immune response in refractory patients to standard treatment. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1342] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
6
|
Merlotti A, Taglianti RV, Melano A, Gianello L, Reali A, Petrucci R, Russi EG. Letter to the editor regarding Wei W et al.: “Experience of the Hubei cancer hospital in Wuhan, China”. Radiother Oncol 2020; 150:183. [PMID: 32621831 PMCID: PMC7327443 DOI: 10.1016/j.radonc.2020.06.035] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2020] [Accepted: 06/20/2020] [Indexed: 11/29/2022]
Affiliation(s)
- Anna Merlotti
- Department of Radiation Oncology, S. Croce and Carle Teaching Hospital, Cuneo, Italy.
| | | | - Antonella Melano
- Department of Radiation Oncology, S. Croce and Carle Teaching Hospital, Cuneo, Italy
| | - Luca Gianello
- Department of Radiation Oncology, S. Croce and Carle Teaching Hospital, Cuneo, Italy
| | - Alessia Reali
- Department of Radiation Oncology, S. Croce and Carle Teaching Hospital, Cuneo, Italy
| | - Rachele Petrucci
- Department of Radiation Oncology, S. Croce and Carle Teaching Hospital, Cuneo, Italy
| | - Elvio Grazioso Russi
- Department of Radiation Oncology, S. Croce and Carle Teaching Hospital, Cuneo, Italy
| |
Collapse
|
7
|
Merlotti A, Bonomo P, Ragona R, Trovò M, Alongi F, Mazzola R, Vigna Taglianti R, Gianello L, Reali A, Bergesio F, Lucio F, Boriano A, De Maggi A, Russi E. Dose prescription in SBRT for early-stage non-small cell lung cancer: are we all speaking the same language? Tumori 2020; 107:182-187. [PMID: 32515301 DOI: 10.1177/0300891620929425] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
INTRODUCTION Stereotactic body radiation therapy is increasingly used in the treatment of early-stage lung cancers. Guidelines provide indications regarding the constraints to the organs at risk (OARs) and the minimum coverage of the planning target volume but do not suggest optimal dose distribution. Data on dose distribution from the different published series are not comparable due to different prescription modalities and reported dose parameters. METHODS We conducted a review of the published data on dose prescription, focusing on the role of homogeneity on local tumor control, and present suggestions on how to specify and report the prescriptions to permit comparisons between studies or between cases from different centers. CONCLUSIONS To identify the dose-prescription modality that better correlates with oncologic outcomes, future studies should guarantee a close uniformity of dose distribution between cases and complete dose parameters reporting for treatment volumes and OARs.
Collapse
Affiliation(s)
- Anna Merlotti
- Radiation Oncology, Santa Croce e Carle Hospital, Cuneo, Italy
| | | | | | - Marco Trovò
- Department of Radiation Oncology, Azienda Sanitaria Universitaria Integrata UD, Udine, Italy
| | - Filippo Alongi
- Radiation Oncology Department, IRCCS Sacro Cuore Don Calabria Hospital, Negrar, Italy
| | - Rosario Mazzola
- Radiation Oncology Department, IRCCS Sacro Cuore Don Calabria Hospital, Negrar, Italy
| | | | - Luca Gianello
- Radiation Oncology, Santa Croce e Carle Hospital, Cuneo, Italy
| | - Alessia Reali
- Radiation Oncology, Santa Croce e Carle Hospital, Cuneo, Italy
| | | | | | | | | | - Elvio Russi
- Radiation Oncology, Santa Croce e Carle Hospital, Cuneo, Italy
| |
Collapse
|
8
|
DE Sanctis V, Belgioia L, Cante D, LA Porta MR, Caspiani O, Guarnaccia R, Argenone A, Muto P, Musio D, DE Felice F, Maurizi F, Bunkhelia F, Ruo Redda MG, Reali A, Valeriani M, Osti MF, Alterio D, Bacigalupo A, Russi EG. Lactobacillus brevis CD2 for Prevention of Oral Mucositis in Patients With Head and Neck Tumors: A Multicentric Randomized Study. Anticancer Res 2019; 39:1935-1942. [PMID: 30952736 DOI: 10.21873/anticanres.13303] [Citation(s) in RCA: 48] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2019] [Revised: 02/28/2019] [Accepted: 03/04/2019] [Indexed: 11/10/2022]
Abstract
BACKGROUND Oropharyngeal mucositis occurs in virtually all patients with head and neck cancer receiving radiochemotherapy. The manipulation of the oral cavity microbiota represents an intriguing and challenging target. PATIENTS AND METHODS A total of 75 patients were enrolled to receive Lactobacillus brevis CD2 lozenges or oral care regimen with sodium bicarbonate mouthwashes. The primary endpoint was the incidence of grade 3 or 4 oropharyngeal mucositis during radiotherapy treatment. RESULTS There was no statistical difference in the incidence of grade 3-4 oropharyngeal mucositis between the intervention and control groups (40.6% vs. 41.6% respectively, p=0.974). The incidence of pain, dysphagia, body weight loss and quality of life were not different between the experimental and standard arm. CONCLUSION Our study was not able to demonstrate the efficacy of L. brevis CD2 lozenges in preventing radiation-induced mucositis in patients with head and neck cancer. Although modulating homeostasis of the salivary microbiota in the oral cavity seems attractive, it clearly needs further study.
Collapse
Affiliation(s)
- Vitaliana DE Sanctis
- Department of Medicine and Surgery and Translational Medicine, Radiation Oncology, S. Andrea Hospital, Sapienza University of Rome, Rome, Italy
| | - Liliana Belgioia
- Radiation Oncology, Policlinico San Martino and University, Genoa, Italy
| | - Domenico Cante
- Department of Radiation Oncology, ASL Turin 4, Ivrea Community Hospital, Ivrea, Italy
| | - Maria R LA Porta
- Department of Radiation Oncology, ASL Turin 4, Ivrea Community Hospital, Ivrea, Italy
| | | | | | - Angela Argenone
- Radiation Oncology, Istituto Nazionale Tumori-IRCCS-G. Pascale Foundation, Naples, Italy
| | - Paolo Muto
- Radiation Oncology, Istituto Nazionale Tumori-IRCCS-G. Pascale Foundation, Naples, Italy
| | - Daniela Musio
- Department of Radiological, Oncological and Anatomo-pathological Sciences, Radiation Oncology, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
| | - Francesca DE Felice
- Department of Radiological, Oncological and Anatomo-pathological Sciences, Radiation Oncology, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
| | - Francesca Maurizi
- Radiation Oncology, A.O. Ospedali Riuniti Marche Nord, Pesaro, Italy
| | - Feisal Bunkhelia
- Radiation Oncology, A.O. Ospedali Riuniti Marche Nord, Pesaro, Italy
| | - Maria Grazia Ruo Redda
- Department of Oncology, Radiation Oncology, University of Turin, S. Luigi Gonzaga Hospital, Orbassano, Italy
| | - Alessia Reali
- Department of Oncology, Radiation Oncology, University of Turin, S. Luigi Gonzaga Hospital, Orbassano, Italy
| | - Maurizio Valeriani
- Department of Medicine and Surgery and Translational Medicine, Radiation Oncology, S. Andrea Hospital, Sapienza University of Rome, Rome, Italy
| | - Mattia F Osti
- Department of Medicine and Surgery and Translational Medicine, Radiation Oncology, S. Andrea Hospital, Sapienza University of Rome, Rome, Italy
| | - Daniela Alterio
- Radiation Oncology, European Institute of Oncology, Milan, Italy
| | | | - Elvio G Russi
- Radiation Oncology, A.S.O. S. Croce e Carle, Cuneo, Italy
| |
Collapse
|
9
|
Allis S, Reali A, Mortellaro G, Arcadipane F, Bartoncini S, Grazia Ruo Redda M. Should Radiotherapy after Primary Systemic Therapy be Administered with the Same Recommendations Made for Operable Breast Cancer Patients who Receive Surgery as first Treatment? A Critical Review. Tumori 2018; 98:543-9. [DOI: 10.1177/030089161209800502] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Primary systemic therapy is not only used in patients with locally advanced inoperable non-metastatic breast cancer but also for operable stage II and III cancer aimed at breast conservation. The indications for local-regional radiotherapy for patients who receive primary systemic therapy are still evolving. The purpose of this article is to provide a comprehensive discussion of how primary systemic therapy in operable breast cancer patients could affect the indications of radiotherapy to optimize local-regional treatment. An overview of available literature data regarding neoadjuvant treatment and radiotherapy is analyzed and discussed. Considering the variability of data on this issue, an appropriate approach could still be to tailor treatment decision to the individual clinical case.
Collapse
Affiliation(s)
- Simona Allis
- Department of Clinical and Biological Sciences, Radiation Oncology Unit, University of Turin, S. Luigi Hospital, Orbassano
| | - Alessia Reali
- Department of Clinical and Biological Sciences, Radiation Oncology Unit, University of Turin, S. Luigi Hospital, Orbassano
| | - Gianluca Mortellaro
- Department of Clinical and Biological Sciences, Radiation Oncology Unit, University of Turin, S. Luigi Hospital, Orbassano
| | - Francesca Arcadipane
- Department of Medical and Surgical Sciences, Radiation Oncology Unit, University of Turin, S Giovanni Battista Hospital, Turin, Italy
| | - Sara Bartoncini
- Department of Medical and Surgical Sciences, Radiation Oncology Unit, University of Turin, S Giovanni Battista Hospital, Turin, Italy
| | - Maria Grazia Ruo Redda
- Department of Clinical and Biological Sciences, Radiation Oncology Unit, University of Turin, S. Luigi Hospital, Orbassano
| |
Collapse
|
10
|
Morganti S, Brambilla N, Petronio A, Reali A, Bedogni F, Auricchio F. Prediction of patient-specific post-operative outcomes of TAVI procedure: The impact of the positioning strategy on valve performance. J Biomech 2016; 49:2513-9. [DOI: 10.1016/j.jbiomech.2015.10.048] [Citation(s) in RCA: 55] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2015] [Accepted: 10/23/2015] [Indexed: 11/28/2022]
|
11
|
Reali A, Allis S, Girardi A, Verna R, Bianco L, Redda MGR. Is Karnofsky Performance Status Correlate with Better Overall Survival in Palliative Conformal Whole Brain Radiotherapy? Our Experience. Indian J Palliat Care 2015; 21:311-6. [PMID: 26600700 PMCID: PMC4617039 DOI: 10.4103/0973-1075.164891] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
AIM Brain metastases (BMs) are a common event in the progression of many human cancers. The aim of this study was to evaluate the potential prognostic factors for the clinical identification of a subgroup of patients that could benefit from whole brain conformal radiotherapy (WBRT). MATERIALS AND METHODS From January 2010 to February 2014, 80 patients with a diagnosis of BMs underwent WBRT at our Radiation Oncology Department, San Luigi Hospital, Italy. Among them, 36 medical records were retrospective reviewed. Gender, age, Karnofsky performance status (KPS), number of BMs on computed tomography and/or magnetic resonance images, presence or absence of perilesional edema, presence or absence of necrosis pattern, and histology of primary tumor were analyzed. Univariate and multivariate analyses were performed. RESULTS In our cohort of patients, significant prognostic factors for 20 months overall survival was KPS> 70, while a statistical trend (P = 0.098) was registered regarding primary breast. CONCLUSION WBRT can be still considered a standard and effective treatment in patients with BMs. High KPS and breast cancer primary tumor seem to be useful parameters for characterize a subgroup of patients with more favorable prognosis.
Collapse
Affiliation(s)
- Alessia Reali
- Department of Oncology, Radiation Oncology Unit, University of Turin, S. Luigi Hospital, Orbassano, Italy
| | - Simona Allis
- Department of Oncology, Radiation Oncology Unit, University of Turin, S. Luigi Hospital, Orbassano, Italy
| | - Andrea Girardi
- Department of Oncology, Radiation Oncology Unit, University of Turin, S. Luigi Hospital, Orbassano, Italy
| | - Roberta Verna
- Department of Oncology, Radiation Oncology Unit, University of Turin, S. Luigi Hospital, Orbassano, Italy
| | - Lavinia Bianco
- Department of Oncology, Radiation Oncology Unit, University of Turin, S. Luigi Hospital, Orbassano, Italy
| | - Maria Grazia Ruo Redda
- Department of Oncology, Radiation Oncology Unit, University of Turin, S. Luigi Hospital, Orbassano, Italy
| |
Collapse
|
12
|
Bianco L, Anglesio S, Verna R, Torti D, Parvis G, Ruo Redda M, Allis S, Reali A. A case report of narrowing primary tracheal mucosa-associated lymphoid tissue lymphoma: A multidisciplinary approach. Clin Cancer Investig J 2015. [DOI: 10.4103/2278-0513.154267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
13
|
Morganti S, Conti M, Aiello M, Valentini A, Mazzola A, Reali A, Auricchio F. Simulation of transcatheter aortic valve implantation through patient-specific finite element analysis: two clinical cases. J Biomech 2014; 47:2547-55. [PMID: 24998989 DOI: 10.1016/j.jbiomech.2014.06.007] [Citation(s) in RCA: 77] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2014] [Revised: 05/27/2014] [Accepted: 06/04/2014] [Indexed: 10/25/2022]
Abstract
Transcatheter aortic valve implantation (TAVI) is a minimally invasive procedure introduced to treat aortic valve stenosis in elder patients. Its clinical outcomes are strictly related to patient selection, operator skills, and dedicated pre-procedural planning based on accurate medical imaging analysis. The goal of this work is to define a finite element framework to realistically reproduce TAVI and evaluate the impact of aortic root anatomy on procedure outcomes starting from two real patient datasets. Patient-specific aortic root models including native leaflets, calcific plaques extracted from medical images, and an accurate stent geometry based on micro-tomography reconstruction are key aspects included in the present study. Through the proposed simulation strategy we observe that, in both patients, stent apposition significantly induces anatomical configuration changes, while it leads to different stress distributions on the aortic wall. Moreover, for one patient, a possible risk of paravalvular leakage has been found while an asymmetric coaptation occurs in both investigated cases. Post-operative clinical data, that have been analyzed to prove reliability of the performed simulations, show a good agreement with analysis results. The proposed work thus represents a further step towards the use of realistic computer-based simulations of TAVI procedures, aiming at improving the efficacy of the operation technique and supporting device optimization.
Collapse
Affiliation(s)
- S Morganti
- University of Pavia, Dept. of Industrial Eng. and Informatics, Via Ferrata 3, 27100 Pavia, Italy.
| | - M Conti
- University of Pavia, Dept. of Civil Eng. and Architecture, Via Ferrata 3, 27100 Pavia, Italy
| | - M Aiello
- IRCCS Policlinico San Matteo, Dept. of Cardiothoracic Surgery, Viale Golgi 19, 27100 Pavia, Italy
| | - A Valentini
- IRCCS Policlinico San Matteo, Institute of Radiology, Viale Golgi 19, 27100 Pavia, Italy
| | - A Mazzola
- IRCCS Policlinico San Matteo, Dept. of Cardiothoracic Surgery, Viale Golgi 19, 27100 Pavia, Italy
| | - A Reali
- University of Pavia, Dept. of Civil Eng. and Architecture, Via Ferrata 3, 27100 Pavia, Italy
| | - F Auricchio
- University of Pavia, Dept. of Civil Eng. and Architecture, Via Ferrata 3, 27100 Pavia, Italy
| |
Collapse
|
14
|
Ruo Redda MG, Allis S, Reali A, Bartoncini S, Roggero S, Anglesio SM, Piga A. Complete recovery from paraparesis in spinal cord compression due to extramedullary haemopoiesis in beta-thalassaemia by emergency radiation therapy. Intern Med J 2014; 44:409-12. [PMID: 24754690 DOI: 10.1111/imj.12386] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2013] [Accepted: 09/29/2013] [Indexed: 11/30/2022]
Abstract
Extramedullary haemopoiesis (EMH) is a complication commonly associated with beta-thalassaemia intermedia; it is frequently asymptomatic but can sometimes lead to symptomatic tumour-like masses. No guidelines or common consensus are available in literature regarding the different treatment strategies and only single cases have been reported. We describe a case of spinal cord compression due to intrathoracic EMH masses treated with combined radiotherapy and hydroxyurea.
Collapse
Affiliation(s)
- M G Ruo Redda
- Radiation Oncology Unit, Department of Oncology, S. Luigi Hospital, University of Turin, Orbassano, Italy
| | | | | | | | | | | | | |
Collapse
|
15
|
Bossi P, Numico G, De Santis V, Ruo Redda MG, Reali A, Belgioia L, Cossu Rocca M, Orlandi E, Airoldi M, Bacigalupo A, Mazzer M, Saibene G, Russi E. Prevention and treatment of oral mucositis in patients with head and neck cancer treated with (chemo) radiation: report of an Italian survey. Support Care Cancer 2014; 22:1889-96. [PMID: 24566870 DOI: 10.1007/s00520-014-2166-7] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2013] [Accepted: 02/05/2014] [Indexed: 12/31/2022]
Abstract
PURPOSE There is a limited number of therapies with a high level of recommendations for mucositis, while several strategies are currently employed with a limited evidence for efficacy. A national survey among Italian oncologists who treat head and neck cancer (HNC) was conducted in order to assess the most common preventive and therapeutic protocols (including nutritional support and pain control) for oral mucositis (OM) in patients undergoing chemoradiotherapy. METHODS From September to November 2012, a nationwide electronic survey with 21 focused items was proposed to chemotherapy and radiotherapy centers. RESULTS We collected 111 answers. Common Terminology Criteria for Adverse Events (CTCAE) scale is employed by 55% of the physicians in assessing mucosal toxicity. The most relevant predictive factors for OM development are considered smoke, alcohol use, planned radiotherapy, and concurrent use of radiosensitizing chemotherapy. Prophylactic gastrostomy is adopted in <10% of the patients. Preventive antibiotics or antimycotics are prescribed by 46% of the responders (mainly local or systemic antimycotic drugs). Alkalinizing mouthwashes or coating agents are frequently adopted (70% of the cases). Among therapeutic interventions, systemic fluconazole is administered by 80% of the physicians. Pain is mainly treated by weak followed by strong opioids. CONCLUSIONS A variety of preventive and therapeutic protocols for OM exists among the participating Italian centers, with some uniformity in respect to nutritional support, use of antimycotic and painkillers. There is an urgent need for well-conducted clinical trials aimed at assessing the best choices for OM prevention and treatment in HNC.
Collapse
Affiliation(s)
- Paolo Bossi
- Head and Neck Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy,
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Moretto F, Rampino M, Munoz F, Ruo Redda MG, Reali A, Balcet V, Badellino S, Piva C, Schena M, Airoldi M, Ostellino O, Pecorari G, Ragona R, Ricardi U. Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment. Radiol Med 2014; 119:634-41. [PMID: 24424659 DOI: 10.1007/s11547-013-0359-7] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/04/2013] [Accepted: 05/13/2013] [Indexed: 11/29/2022]
Abstract
PURPOSE Nasopharyngeal carcinoma represents a distinct entity as compared to other head and neck tumours. Radio-chemotherapy is the treatment of first choice in non-metastatic disease. Intensity-modulated radiation therapy (IMRT) allows the sparing of parotid glands, improving the toxicity profile. The aim of this study was to compare the results obtained with IMRT with those obtained with conventional 2D (2DRT) and 3D conformal radiation therapy (3DCRT) in terms of tumour control, survival, acute and late toxicity. MATERIALS AND METHODS We reviewed the clinical records of 52 patients with histologically proven carcinoma of the nasopharynx (stage I-IVB according to the 2002 American Joint Committee on Cancer staging system) treated with curative intent between January 2003 and August 2011: 26 patients were treated with 2D or 3D technique (arm A) and 26 with IMRT technique (arm B) with simultaneous integrated boost. Fifty patients (96 %) received chemotherapy. Local control (LC), locoregional control (LRC), disease-free survival (DFS), overall survival (OS), acute and late toxicity were retrospectively evaluated. RESULTS After a median follow-up of 37.6 months (69 months in arm A and 23 months in arm B), 69 % of patients were alive and disease-free, 10 % were alive with disease and 21 % died of disease, with an OS of 81 % at 2 years and 79 % at 5 years, a LC rate of 88 % at 2 years and 78 % at 5 years, a LRC rate of 80 % at 2 years and 73 % at 5 years and a DFS of 74 % at 2 years and 65 % at 5 years, with no statistically significant differences between IMRT and 2DRT/3DCRT. In multivariate analysis, the TNM stage and the volume treated at high dose correlated with DFS. No factor was found to be related to OS. Chronic toxicity was not statistically different in the two study groups and in particular ≥ G2 xerostomia rates were 67 and 41 % in arm A and B, respectively (p = 0.10). CONCLUSIONS The findings of this study confirm that IMRT associated with chemotherapy, even with moderately hypofractionated regimens, allows good disease control with better results in terms of late xerostomia, although without statistically significant differences compared to 2DRT and 3DCRT. The hypothesis of an impact of IMRT on survival has yet to be confirmed.
Collapse
Affiliation(s)
- Francesco Moretto
- Dipartimento di Oncologia, Radioterapia U, Università di Torino, Turin, Italy,
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Ruo Redda M, Reali A, Allis S, Anglesio S, Verna R, Bianco L. Letter to the Editor concerning Bhandari et al. "Impact of repeat computerized tomography replans in the radiation therapy of head and neck cancers". J Med Phys 2014; 39:259-60. [PMID: 25525315 PMCID: PMC4258735 DOI: 10.4103/0971-6203.144496] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
18
|
Ruo Redda MG, Anglesio SM, Allis S, Verna R, Girardi A, Bianco L, Trevisiol E, Reali A. Letter to the editor concerning Tsuchiya K et al. "Dosimetric comparison between intensity-modulated radiotherapy and standard wedged tangential technique for whole-breast radiotherapy in Asian women with relatively small breast volumes". Radiol Phys Technol 2013; 7:387-8. [PMID: 24293344 DOI: 10.1007/s12194-013-0248-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2013] [Revised: 11/08/2013] [Accepted: 11/13/2013] [Indexed: 10/26/2022]
Affiliation(s)
- Maria Grazia Ruo Redda
- Department of Oncology, Radiation Oncology, University of Turin, S. Luigi Gonzaga Hospital, Regione Gonzole 10, Orbassano, 10043, Turin, Italy,
| | | | | | | | | | | | | | | |
Collapse
|
19
|
Abstract
When considering whether to administer drugs to women during pregnancy and lactation, we have to take into account that these substances may expose the fetus or neonate to multiple effects. This occurs because there is a unique situation where the maternal compartment is connected with the fetal or neonatal compartment through, respectively, the placental barrier or breast milk. The fetus in utero and the breast-fed neonate are to be considered as organisms exposed and sensitive to the effects of drugs that cross the placenta or enter the breast milk. This review focuses on the most frequently used antibiotics during pregnancy and lactation and presents useful suggestions for daily practice. Drugs that must be avoided are clearly underlined.
Collapse
Affiliation(s)
- A Reali
- Neonatal Pathology and Intensive Care Unit, University of Cagliari, Italy
| | | | | | | |
Collapse
|
20
|
Reali A, Mortellaro G, Allis S, Trevisiol E, Anglesio SM, Bartoncini S, Ruo Redda MG. A case of primary mediastinal Ewing's sarcoma / primitive neuroectodermal tumor presenting with initial compression of superior vena cava. Ann Thorac Med 2013; 8:121-3. [PMID: 23741276 PMCID: PMC3667441 DOI: 10.4103/1817-1737.109834] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/22/2012] [Accepted: 04/19/2012] [Indexed: 11/04/2022] Open
Abstract
Ewing's sarcomas and peripheral primitive neuroectodermal tumors (ES/PNETs) are high grade malignant neoplasms. These malignancies are characterized by a chromosome 22 rearrangement, arise from bone or soft tissue, predominantly affect children and young adults, and are grouped in the Ewing family of tumors. Multimodality treatment programs are the treatment of choice. Primary localization of ES/PNET in the mediastinum is extremely rare. We describe a case of ES/PNET presenting as a mediastinal mass with tracheal compression and initial signs of superior vena cava in a 66-year-old woman.
Collapse
Affiliation(s)
- Alessia Reali
- Radiation Oncology Unit, University of Turin, S. Luigi Hospital, Orbassano, Italy
| | | | | | | | | | | | | |
Collapse
|
21
|
Auricchio F, Conti M, Ferrara A, Morganti S, Reali A. Patient-specific finite element analysis of carotid artery stenting: a focus on vessel modeling. Int J Numer Method Biomed Eng 2013; 29:645-664. [PMID: 23729192 DOI: 10.1002/cnm.2511] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/08/2011] [Revised: 07/25/2012] [Accepted: 08/13/2012] [Indexed: 06/02/2023]
Abstract
Finite element analysis is nowadays a well-assessed technique to investigate the impact of stenting on vessel wall and, given the rapid progression of both medical imaging techniques and computational methods, the challenge of using the simulation of carotid artery stenting as procedure planning tool to support the clinical practice can be approached. Within this context, the present study investigates the impact of carotid stent apposition on carotid artery anatomy by means of patient-specific finite element analysis. In particular, we focus on the influence of the vessel constitutive model on the prediction of carotid artery wall tensional state of lumen gain and of vessel straightening. For this purpose, we consider, for a given stent design and CA anatomy, two constitutive models for the CA wall, that is, a hyperelastic isotropic versus a fiber-reinforced hyperelastic anisotropic model. Despite both models producing similar patterns with respect to stress distribution, the anisotropic model predicts a higher vessel straightening and a more evident discontinuity of the lumen area near the stent ends as observed in the clinical practice. Although still affected by several simplifications, the present study can be considered as further step toward a realistic simulation of carotid artery stenting.
Collapse
Affiliation(s)
- F Auricchio
- Department of Civil Engineering and Architecture, Structural Mechanics Division, University of Pavia, Via Ferrata 1, 27100 Pavia, Italy
| | | | | | | | | |
Collapse
|
22
|
Auricchio F, Conti M, Morganti S, Reali A. Simulation of transcatheter aortic valve implantation: a patient-specific finite element approach. Comput Methods Biomech Biomed Engin 2013; 17:1347-57. [DOI: 10.1080/10255842.2012.746676] [Citation(s) in RCA: 55] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
|
23
|
Allis S, Reali A, Mortellaro G, Arcadipane F, Bartoncini S, Ruo Redda MG. Should radiotherapy after primary systemic therapy be administered with the same recommendations made for operable breast cancer patients who receive surgery as first treatment? A critical review. Tumori 2013. [PMID: 23235747 DOI: 10.1700/1190.13193] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Primary systemic therapy is not only used in patients with locally advanced inoperable non-metastatic breast cancer but also for operable stage II and III cancer aimed at breast conservation. The indications for local-regional radiotherapy for patients who receive primary systemic therapy are still evolving. The purpose of this article is to provide a comprehensive discussion of how primary systemic therapy in operable breast cancer patients could affect the indications of radiotherapy to optimize local-regional treatment. An overview of available literature data regarding neoadjuvant treatment and radiotherapy is analyzed and discussed. Considering the variability of data on this issue, an appropriate approach could still be to tailor treatment decision to the individual clinical case.
Collapse
Affiliation(s)
- Simona Allis
- Department of Clinical and Biological Sciences, Radiation Oncology Unit, University of Turin,S. Luigi Hospital, Orbassano, Italy
| | | | | | | | | | | |
Collapse
|
24
|
Auricchio F, Conti M, Marconi S, Reali A, Tolenaar JL, Trimarchi S. Patient-specific aortic endografting simulation: from diagnosis to prediction. Comput Biol Med 2013; 43:386-94. [PMID: 23395199 DOI: 10.1016/j.compbiomed.2013.01.006] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2012] [Revised: 01/03/2013] [Accepted: 01/16/2013] [Indexed: 11/29/2022]
Abstract
Traditional surgical repair of ascending aortic pseudoaneurysm is complex, technically challenging, and associated with significant mortality. Although new minimally invasive procedures are rapidly arising thanks to the innovations in catheter-based technologies, the endovascular repair of the ascending aorta is still limited because of the related anatomical challenges. In this context, the integration of the clinical considerations with dedicated bioengineering analysis, combining the vascular features and the prosthesis design, might be helpful to plan the procedure and predict its outcome. Moving from such considerations, in the present study we describe the use of a custom-made stent-graft to perform a fully endovascular repair of an asymptomatic ascending aortic pseudoaneurysm in a patient, who was a poor candidate for open surgery. We also discuss the possible contribution of a dedicated medical images analysis and patient-specific simulation as support to procedure planning. In particular, we have compared the simulation prediction based on pre-operative images with post-operative outcomes. The agreement between the computer-based analysis and reality encourages the use of the proposed approach for a careful planning of the treatment strategy and for an appropriate patient selection, aimed at achieving successful outcomes for endovascular treatment of ascending aortic pseudoaneurysms as well as other aortic diseases.
Collapse
Affiliation(s)
- F Auricchio
- Department of Civil Engineering and Architecture, University of Pavia, Pavia, Italy
| | | | | | | | | | | |
Collapse
|
25
|
Auricchio F, Conti M, Ferraro M, Reali A. Evaluation of carotid stent scaffolding through patient-specific finite element analysis. Int J Numer Method Biomed Eng 2012; 28:1043-1055. [PMID: 23027634 DOI: 10.1002/cnm.2509] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/11/2012] [Revised: 07/05/2012] [Accepted: 08/03/2012] [Indexed: 06/01/2023]
Abstract
After carotid artery stenting, the plaque remains contained between the stent and the vessel wall, moving consequently physicians' concerns toward the stent capability of limiting the plaque protrusion, that is, toward vessel scaffolding, to avoid that some debris is dislodged after the procedure. Vessel scaffolding is usually measured as the cell area of the stent in free-expanded configuration, neglecting thus the actual stent configuration within the vascular anatomy. In the present study, we measure the cell area of four different stent designs deployed in a realistic carotid artery model through patient-specific finite element analysis. The results suggest that after deployment, the cell area change along the stent length and the related reduction with respect to the free-expanded configuration are functions of the vessel tapering. Hence, the conclusions withdrawn from the free-expanded configuration appear to be qualitatively acceptable for comparative purposes, but they should be carefully handled because they neglect the post-implant variability, which seems to be more pronounced in open-cell designs, especially at the bifurcation segment. Even though the investigation is limited to few stent designs and one vascular anatomy, our study confirms the capability of dedicated computer-based simulations to provide useful information about complex stent features as vessel scaffolding.
Collapse
Affiliation(s)
- F Auricchio
- Dipartimento di Ingegneria Civile ed Architettura, Università degli Studi di Pavia, Via Ferrata 1, 27100, Pavia, Italy
| | | | | | | |
Collapse
|
26
|
Auricchio F, Conti M, Ferrara A, Morganti S, Reali A. Patient-specific simulation of a stentless aortic valve implant: the impact of fibres on leaflet performance. Comput Methods Biomech Biomed Engin 2012; 17:277-85. [DOI: 10.1080/10255842.2012.681645] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
27
|
Rampino M, Bacigalupo A, Russi E, Schena M, Lastrucci L, Iotti C, Reali A, Musu A, Balcet V, Piva C, Bustreo S, Munoz F, Ragona R, Corvò R, Ricardi U. Efficacy and feasibility of induction chemotherapy and radiotherapy plus cetuximab in head and neck cancer. Anticancer Res 2012; 32:195-199. [PMID: 22213307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
BACKGROUND To determine the potential activity and tolerability of sequential treatment in head and neck cancer, we conducted a phase II trial based on induction chemotherapy of two cycles of taxotere, cisplatin and 5-fluorouracil followed by radiotherapy plus weekly cetuximab. PATIENTS AND METHODS Thirty-six patients with stage III or IV squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx were treated and evaluated for response and acute toxicity. RESULTS Eighty-one percent of patients had stage IV disease and 42% had hypopharyngeal and oral cavity primaries. The overall response rate was 81.8%, with 60.6% complete response and 33.3% partial response. Severe toxicities were febrile neutropenia (6%) during induction chemotherapy and dermatitis (48%), mucositis (33%) and dysphagia (12%) during the concurrent phase. CONCLUSION Our protocol proved to be feasible, effective and well tolerated. This sequential strategy should be further investigated.
Collapse
Affiliation(s)
- M Rampino
- Department of Medical and Surgical Sciences, Radiation Oncology Unit, University of Torino, San Giovanni Battista Hospital, Torino, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Fanos V, Puddu M, Reali A, Atzei A, Zaffanello M. Perinatal nutrient restriction reduces nephron endowment increasing renal morbidity in adulthood: a review. Early Hum Dev 2010; 86 Suppl 1:37-42. [PMID: 20153126 DOI: 10.1016/j.earlhumdev.2010.01.007] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
Perinatal malnutrition has been included among the causes of renal disease in adulthood. Here, we consider the relationships between early supply of specific nutrients (such as protein, fat, vitamins and electrolytes) and renal endowment. Prenatal and postnatal nutrition mismatch is also discussed. In addition, this article presents the role of nutrition of both mothers and pre-term infants on nephron endowment, with final practical considerations.
Collapse
Affiliation(s)
- V Fanos
- Neonatal Intensive Care Unit, Puericultura Institute and Neonatal Section, University and Azienda Mista of Cagliari, Italy.
| | | | | | | | | |
Collapse
|
29
|
Garzaro M, Pecorari G, Landolfo V, Campisi P, Reali A, Giordano C. Nasopharyngeal polymorphous low-grade adenocarcinoma in a patient with nonfunctioning pituitary macroadenoma. B-ENT 2010; 6:59-62. [PMID: 20420083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/29/2023] Open
Abstract
BACKGROUND Polymorphous low grade adenocarcinoma (PLGA) is a rare malignant neoplasm of the minor salivary glands occurring in the fifth and sixth decade with a 2:1 female predominance. The nasal cavity is involved in less than 1% of cases. The incidence of clinically recognisable pituitary adenoma is 15 cases/million/year. The prevalence of non-functioning pituitary adenoma (NFPA) is estimated to be 70-90 cases/million. Both types of adenoma represent 20-45% of pituitary tumours. CASE REPORT The report describes the first case of PLGA associated with NFPA, both incidentally diagnosed. Three months after the exeresis of the NFPA using a trans-sphenoidal approach, an endoscopic resection of the PLGA was performed. No recurrence was observed during a 13 months follow-up. CONCLUSIONS Complete surgical excision is the preferred management for PLGA. Radiotherapy has not been demonstrated to be effective in treating PLGA. The prognosis is good with a very low rate of metastasis and local recurrence.
Collapse
Affiliation(s)
- M Garzaro
- I ENT Clinic, Physiopathology Department, University of Turin, Turin, Italy.
| | | | | | | | | | | |
Collapse
|
30
|
Buselli R, Galli G, Cristaudo A, Franco F, Possemato A, Ansuini R, Taddeo D, Battaglia S, Roselli MG, Leoni MG, Reali A, Parducci D, Degaetano R, Fani F, Boccuzzi MT, Cassitto MG. [Risk assessment method for psychosocial factors at workplace: a North-West Tuscany area project]. G Ital Med Lav Ergon 2007; 29:360-362. [PMID: 18409725] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
The rising awareness of psychosocial risks at workplace means that it is ever more important to prepare methods to assess psychosocial factors in occupational environment. This project of north west tuscany area has the aim to realize an instrument for a gradual risk assessment for this kind of factors without the support of specialists. A decisional flow chart helps to approach the risk assessment step by step on the basis of company features, management and organization problems and company symptoms of stress. The final assessment combines the evaluation of perceived risks with job analysis realizing a matrix containing 5 risk levels, which suggests the priority of preventive measures. The intermediate level (level three) represents the activation level for the medical surveillance. This experience means a proposal for a quantitative assessment of psychosocial risks at workplace.
Collapse
|
31
|
De Vivo L, Derrico P, Tomaiuolo D, Capussotto C, Reali A. Evaluating alternative service contracts for medical equipment. Conf Proc IEEE Eng Med Biol Soc 2007; 2004:3485-8. [PMID: 17271037 DOI: 10.1109/iembs.2004.1403978] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/13/2023]
Abstract
Managing medical equipments is a formidable task that has to be pursued maximizing the benefits within a highly regulated and cost-constrained environment. Clinical engineers are uniquely equipped to determine which policies are the most efficacious and cost effective for a health care institution to ensure that medical devices meet appropriate standards of safety, quality and performance. Part of this support is a strategy for preventive and corrective maintenance. This paper describes an alternative scheme of OEM (Original Equipment Manufacturer) service contract for medical equipment that combines manufacturers' technical support and in-house maintenance. An efficient and efficacious organization can reduce the high cost of medical equipment maintenance while raising reliability and quality. Methodology and results are discussed.
Collapse
Affiliation(s)
- L De Vivo
- Clinical Engineering Department, IRCCS Casa Sollievo della Sofferenza, S. Giovanni Rotondo (FG), Italy
| | | | | | | | | |
Collapse
|
32
|
Aguglia G, Sgreccia A, Bernardo ML, Carmenini E, Giusti De Marle M, Reali A, Morelli S. Left ventricular diastolic function in systemic sclerosis. J Rheumatol 2001; 28:1563-7. [PMID: 11469462] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/20/2023]
Abstract
OBJECTIVE To assess left ventricular diastolic function in patients with systemic sclerosis (SSc) and to verify if a "primary" diastolic dysfunction might exist. METHODS In total 124 patients and 41 healthy subjects underwent complete echocardiographic examination. The following pulsed wave Doppler variables were evaluated: peak velocity during early filling (E), peak velocity during late atrial filling (A), E/A ratio, and early filling deceleration time. RESULTS Seventy-seven patients (62.1%) had conditions potentially affecting left ventricular diastolic function (Group A) and 47 patients (37.9%) formed a homogeneous group without cardiac involvement or other causes of abnormal diastolic function (i.e., systemic and/or pulmonary hypertension, ventricular hypertrophy, pericardial disease, systolic dysfunction, valvular heart disease, coronary artery disease) (Group B). The entire SSc population and Group A showed significant differences in the Doppler variables of diastolic function compared to the control group. No significant differences were found between Group B and controls. CONCLUSION In patients with SSc, left ventricular diastolic dysfunction was found only in patients with conditions potentially affecting left ventricular diastolic function. In patients without conditions potentially affecting left ventricular diastolic function no differences were seen in comparison with controls. SSc does not seem to cause "primary" diastolic abnormalities.
Collapse
Affiliation(s)
- G Aguglia
- Istituto di Clinica Medica I, Università La Sapienza, Rome, Italy
| | | | | | | | | | | | | |
Collapse
|
33
|
Airapetian A, Akopov N, Amarian M, Aschenauer EC, Avakian H, Avakian R, Avetissian A, Avetissian E, Bains B, Baumgarten C, Beckmann M, Belostotski S, Belz JE, Benisch T, Bernreuther S, Bianchi N, Blouw J, Böttcher H, Borissov A, Bouwhuis M, Brack J, Brauksiepe S, Braun B, Bray B, Brons S, Brückner W, Brüll A, Bruins EEW, Bulten HJ, Capitani GP, Carter P, Chumney P, Cisbani E, Court GR, Dalpiaz PF, De Sanctis E, De Schepper D, Devitsin E, de Witt Huberts PKA, Di Nezza P, Düren M, Dvoredsky A, Elbakian G, Ely J, Fantoni A, Fechtchenko A, Ferstl M, Fiedler K, Filippone BW, Fischer H, Fox B, Franz J, Frullani S, Funk MA, Gärber Y, Gao H, Garibaldi F, Gavrilov G, Geiger P, Gharibyan V, Golendukhin A, Graw G, Grebeniouk O, Green PW, Greeniaus LG, Grosshauser C, Guidal M, Gute A, Gyurjyan V, Haas JP, Haeberli W, Hansen JO, Hartig M, Hasch D, Häusser O, Heinsius FH, Henderson R, Henoch M, Hertenberger R, Holler Y, Holt RJ, Hoprich W, Ihssen H, Iodice M, Izotov A, Jackson HE, Jgoun A, Kaiser R, Kinney E, Kisselev A, Kitching P, Kobayashi H, Koch N, Königsmann K, Kolstein M, Kolster H, Korotkov V, Korsch W, Kozlov V, Kramer LH, Krivokhijine VG, Kurisuno M, Kyle G, Lachnit W, Lenisa P, Lorenzon W, Makins NCR, Martens FK, Martin JW, Masoli F, Mateos A, McAndrew M, McIlhany K, McKeown RD, Meissner F, Menden F, Metz A, Meyners N, Mikloukho O, Miller CA, Miller MA, Milner R, Most A, Muccifora V, Mussa R, Nagaitsev A, Naryshkin Y, Nathan AM, Neunreither F, Niczyporuk M, Nowak WD, Nupieri M, Oganessyan KA, O'Neill TG, Openshaw R, Ouyang J, Owen BR, Papavassiliou V, Pate SF, Pitt M, Potashov S, Potterveld DH, Rakness G, Reali A, Redwine R, Reolon AR, Ristinen R, Rith K, Rossi P, Rudnitsky S, Ruh M, Ryckbosch D, Sakemi Y, Savin I, Scarlett C, Schäfer A, Schmidt F, Schmitt H, Schnell G, Schüler KP, Schwind A, Seibert J, Shibata TA, Shibatani K, Shin T, Shutov V, Simani C, Simon A, Sinram K, Slavich P, Spengos M, Steffens E, Stenger J, Stewart J, Stoesslein U, Sutter M, Tallini H, Taroian S, Terkulov A, Teryaev O, Thomas E, Tipton B, Tytgat M, Urciuoli GM, van den Brand JFJ, van der Steenhoven G, van de Vyver R, van Hunen JJ, Vetterli MC, Vikhrov V, Vincter MG, Visser J, Volk E, Wander W, Wendland J, Williamson SE, Wise T, Woller K, Yoneyama S, Zohrabian H. Evidence for a single-spin azimuthal asymmetry in semi-inclusive pion electroproduction. Phys Rev Lett 2000; 84:4047-4051. [PMID: 10990607 DOI: 10.1103/physrevlett.84.4047] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/28/1999] [Indexed: 05/23/2023]
Abstract
Single-spin asymmetries for semi-inclusive pion production in deep-inelastic scattering have been measured for the first time. A significant target-spin asymmetry of the distribution in the azimuthal angle straight phi of the pion relative to the lepton scattering plane was formed for pi(+) electroproduction on a longitudinally polarized hydrogen target. The corresponding analyzing power in the sinstraight phi moment of the cross section is 0.022+/-0.005+/-0.003. This result can be interpreted as the effect of terms in the cross section involving chiral-odd spin distribution functions in combination with a chiral-odd fragmentation function that is sensitive to the transverse polarization of the fragmenting quark.
Collapse
|
34
|
Giancaspro G, Soldini M, Reali A, Ogbonna N, Terrinoni R, Capici F, Barbaro G. [Iatrogenic sequelae of pulmonary tuberculosis]. Clin Ter 1999; 150:203-7. [PMID: 10528432] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/14/2023]
Abstract
OBJECTIVES The purpose of this study is to underline how topical is the chapter of the sequelae of pulmonary tuberculosis and to try to make a classification. Pulmonary tuberculosis can be cured definitely or hesitate in disease (BK negative) that is totally independent from tuberculosis about their pathogenesis and clinical features. They are called sequelae. MATERIALS AND METHODS We made a statistical analysis that investigate a group of 110 patients without active infection (BK negative) admitted in the hospital because of a sequela of pulmonary tuberculosis. Patients were treated in the past by collapse-therapy or by antibiotic-therapy until their spittle became negative for BK. RESULTS A significant (p < 0.05) relationship between each kind of sequela, among the most important ones (fibrothorax, interstitial fibrosis, bronchiectasis, empyema with or without pleural fistula, parafibrotic emphysema), and type of treatment, results. CONCLUSIONS The sequelae of tuberculosis of the lung are highly disadvantageous for people who are affected; are observed frequently; are closely dependent on what kind of treatment the patient has received; are classified in iatrogenic, not iatrogenic or mixed.
Collapse
Affiliation(s)
- G Giancaspro
- D.E.A., Dipartimento di Emergenza Accettazione di II livello, Policlinico Umberto I, Università degli Studi La Sapienza di Roma, Italia.
| | | | | | | | | | | | | |
Collapse
|
35
|
Testa M, Reali A, Copula M, Pinna B, Birocchi F, Pisu C, Chiappe F. Role of rHuEpo on blood transfusions in preterm infants after the fifteenth day of life. Pediatr Hematol Oncol 1998; 15:415-20. [PMID: 9783307 DOI: 10.3109/08880019809016569] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
The specific aim of the study was to assess the safety and efficacy of recombinant human erythropoietin (rHuEpo) in reducing the need for blood transfusions in preterm infants after the 15th day of life. Between 1 October 1994 and 1 October 1995, 107 preterm infants, gestational age < or = 34 weeks, were admitted to the Neonatal Intensive Care Unit and received rHuEpo subcutaneously, 900 U/kg week-1, 3 times weekly, supplemented with iron and vitamin E. Treatment was started at 8 days of life and lasted from a minimum of 6 weeks to a maximum of 3 months. A total of 116 preterm infants of the same gestational age, admitted to the Neonatal Intensive Care Unit from 1 January 1992 to 31 December 1992, served as controls. Entry criteria were gestational age < or = 34 weeks and no major congenital malformation. There were no differences in routine care between the two groups. Hematological measurements and transfusion requirements were followed during therapy. The infants were divided into two groups according to birth weight (< 1500 g and > or = 1500 g), and for each group the number of patients who received blood transfusions and when blood transfusions occurred, before or after the 15th day of life, was recorded. There was a statistically significant difference only for transfusions carried out after the 15th day of life (p < 0.002). No adverse effects attributable to rHuEpo during the treatment were noted. The results indicate that early rHuEpo treatment, in combination with iron supplements, is effective in reducing the need for blood transfusions in preterm infants after the 15th day of life.
Collapse
Affiliation(s)
- M Testa
- Istituto di Patologia e Terapia Intensiva Neonatale, Università di Cagliari, Italy
| | | | | | | | | | | | | |
Collapse
|